Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $20.15 USD
Change Today +0.10 / 0.50%
Volume 462.7K
As of 8:10 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

medassets inc (MDAS) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/30/14 - $25.57
52 Week Low
02/18/15 - $17.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDASSETS INC (MDAS)

medassets inc (MDAS) Related Bloomberg News

View More Bloomberg News

medassets inc (MDAS) Related Businessweek News

View More BusinessWeek News

medassets inc (MDAS) Details

MedAssets, Inc., a performance improvement company, provides technology-enabled products and services for hospitals, health systems, non-acute healthcare providers, payers, and other service providers and product manufacturers in the United States. It operates in two segments, Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM). The SCM segment provides a suite of cost management services, supply chain analytics, and data capabilities; strategic sourcing and group purchasing services; and medical device and clinical resource consulting, lean performance improvement, workforce management, and supply chain outsourcing and procurement services. This segment also provides business intelligence and decision support tools. The RCM segment offers Web-based software and technology-enabled services designed to enhance the revenue performance for healthcare organizations through patient access and financial responsibility, clinical documentation, charge capture and revenue integrity, pricing analysis, claims processing and denials management, payor contract management, extended business office revenue recovery, accounts receivable, and outsourcing services. As of December 31, 2014, the company served approximately 4,500 acute care hospitals and 123,000 ancillary or non-acute provider locations. The company was incorporated in 1999 and is headquartered in Alpharetta, Georgia.

3,350 Employees
Last Reported Date: 03/2/15
Founded in 1999

medassets inc (MDAS) Top Compensated Officers

President, Chief Operating Officer and Direct...
Total Annual Compensation: $577.2K
President of Revenue Cycle Management Segment
Total Annual Compensation: $555.0K
Chief Customer Officer, Senior Executive Vice...
Total Annual Compensation: $578.8K
Chief Strategy & Transformation Officer and E...
Total Annual Compensation: $470.3K
Compensation as of Fiscal Year 2014.

medassets inc (MDAS) Key Developments

Misonix Signs Exclusive Supply Agreement with MedAssets

Misonix announced the launch of an exclusive three-year national supply contract with MedAssets. With MedAssets serving four out of five US hospitals and approximately 123,000 non-acute healthcare providers, Misonix has entered into this exclusive agreement for its BoneScalpel and SonicOne surgical technologies. This is simply a great opportunity for many more healthcare facilities and their patients to ultimately benefit from its BoneScalpel and SonicOne surgical technologies.

MedAssets, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for Twelve Months Ending December 31, 2015

MedAssets, Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported total net revenue of $185,581,000 against $170,867,000 a year ago. Operating income was $17,410,000 against $24,780,000 a year ago. Income before income taxes was $5,603,000 against $13,665,000 a year ago. Net income was $3,353,000 or $0.06 basic and diluted per share against $7,678,000 or $0.12 diluted per share a year ago. Cash provided by operating activities was $34,603,000 against $17,733,000 a year ago. Purchases of property, equipment, and software were $1,322,000 against $1,748,000 a year ago. Capitalized software development costs were $10,054,000 against $8,383,000 a year ago. Non-GAAP EBITDA was $46,851,000 against $50,828,000 a year ago. Total non-GAAP adjusted EBITDA was $57,373,000 against $56,717,000 a year ago. Non-GAAP free cash flow was $23,227,000 against $7,602,000 a year ago. Non-GAAP adjusted net income was $18,766,000 or $0.31 diluted per share against $19,693,000 or $0.32 diluted per share a year ago. The company provided earnings guidance for twelve months ending December 31, 2015. For the year, the company expects net income in the range of between $15,200,000 to $21,000,000, interest expense, net in the range of between $47,600,000 to $47,600,000, non-GAAP EBITDA in the range of between $195,300,000 to $205,300,000 and non-GAAP adjusted EBITDA in the range of between $227,000,000 to $237,000,000, EPS - diluted in the range of between $0.24 to $0.34 and non-GAAP adjusted EPS - diluted in the range of between $1.13 to $1.23. The company used a tax rate of 40.0% for the full year ending December 31, 2015 to calculate the tax effect of each adjustment since it believes 40.0% will be the company's normalized long-term tax rate.

Athens Regional Medical Center Expands Engagement with Medassets for Revenue Cycle Optimization

MedAssets announced that Athens Regional Medical Center (ARMC), the 350-plus bed anchor hospital for Athens Regional Health System, has expanded its engagement with the company in a broad-scale technology initiative designed to optimize revenue cycle operations. ARMC's multi-phased agreement will deploy MedAssets end-to-end portfolio of Revenue Cycle Management (RCM) solutions to upgrade and standardize its technology environment. The new, expanded agreement builds upon ARMC's use of MedAssetsCharge, Pricing and Compliance Solutions for more accurate and compliant charging as well as defensible and consistent pricing for improved revenue capture and reimbursement. To support its broad-scale RCM initiative, the following MedAssets solutions were selected to support ARMC's operational focus: Contract and Episode Management Solutions, to improve payor contract analysis and revenue forecasting, and better identify underpayments to capture increased net revenue, Claims and Billing Solutions that leverage healthcare information management (HIM) and coding expertise to automate the identification of missing charges, overcharges and claim coding errors· Recovery and Collections Solutions that reduce denials and cost to collect, as well as improve staff workflow and decision support capabilities to capture and prioritize all necessary collections data· Patient Access Solutions that offer pricing transparency for patient financial clearance and increased automation and accuracy in upfront collection of patient out-of-pocket responsibilities.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDAS:US $20.15 USD +0.10

MDAS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AMN Healthcare Services Inc $23.16 USD +0.31
Huron Consulting Group Inc $61.00 USD +0.29
Navigant Consulting Inc $14.21 USD -0.08
WebMD Health Corp $42.32 USD -0.68
WNS Holdings Ltd $24.41 USD +0.05
View Industry Companies

Industry Analysis


Industry Average

Valuation MDAS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.6x
Price/Book 2.7x
Price/Cash Flow 14.4x
TEV/Sales 0.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDASSETS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at